Global Pharmaceutical CDMO Solution Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pharmaceutical CDMO Solution market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical CDMO Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical CDMO Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical CDMO Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical CDMO Solution players cover Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Societal CDMO and Aenova Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Pharmaceutical CDMO Solution Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO Solution sales for 2023 through 2029. With Pharmaceutical CDMO Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO Solution industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical CDMO Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO Solution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO Solution market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Pharmaceutical CDMO Solution market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical CDMO Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical CDMO Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical CDMO Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical CDMO Solution players cover Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Societal CDMO and Aenova Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Pharmaceutical CDMO Solution Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO Solution sales for 2023 through 2029. With Pharmaceutical CDMO Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO Solution industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical CDMO Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO Solution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO Solution market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Active Pharmaceutical Ingredient (API) Manufacturing
- Finished Dosage Formulation (FDF) Development and Manufacturing
- Secondary Packaging
- Others
- Innovative Medicine
- Patented Drug
- Patent Expired Drug
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recipharm AB
- Lonza Group
- Catalent
- Patheon (Thermo Fisher Scientific)
- Siegfried AG
- SGS Quay Pharmaceuticals
- Curia
- Societal CDMO
- Aenova Group
- Eurofins CDMO
- Piramal Group
- WuXi AppTec Group
- Fareva
- Strides Pharma Science
- Famar Health Care Service
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Solution Market Size 2018-2029
2.1.2 Pharmaceutical CDMO Solution Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical CDMO Solution Segment by Type
2.2.1 Active Pharmaceutical Ingredient (API) Manufacturing
2.2.2 Finished Dosage Formulation (FDF) Development and Manufacturing
2.2.3 Secondary Packaging
2.2.4 Others
2.3 Pharmaceutical CDMO Solution Market Size by Type
2.3.1 Pharmaceutical CDMO Solution Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical CDMO Solution Segment by Application
2.4.1 Innovative Medicine
2.4.2 Patented Drug
2.4.3 Patent Expired Drug
2.4.4 Others
2.5 Pharmaceutical CDMO Solution Market Size by Application
2.5.1 Pharmaceutical CDMO Solution Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
3 PHARMACEUTICAL CDMO SOLUTION MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Solution Market Size Market Share by Players
3.1.1 Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CDMO Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO SOLUTION BY REGIONS
4.1 Pharmaceutical CDMO Solution Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Solution Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO Solution by Country (2018-2023)
7.2 Europe Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO Solution by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO SOLUTION MARKET FORECAST
10.1 Global Pharmaceutical CDMO Solution Forecast by Regions (2024-2029)
10.1.1 Global Pharmaceutical CDMO Solution Forecast by Regions (2024-2029)
10.1.2 Americas Pharmaceutical CDMO Solution Forecast
10.1.3 APAC Pharmaceutical CDMO Solution Forecast
10.1.4 Europe Pharmaceutical CDMO Solution Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Solution Forecast
10.2 Americas Pharmaceutical CDMO Solution Forecast by Country (2024-2029)
10.2.1 United States Pharmaceutical CDMO Solution Market Forecast
10.2.2 Canada Pharmaceutical CDMO Solution Market Forecast
10.2.3 Mexico Pharmaceutical CDMO Solution Market Forecast
10.2.4 Brazil Pharmaceutical CDMO Solution Market Forecast
10.3 APAC Pharmaceutical CDMO Solution Forecast by Region (2024-2029)
10.3.1 China Pharmaceutical CDMO Solution Market Forecast
10.3.2 Japan Pharmaceutical CDMO Solution Market Forecast
10.3.3 Korea Pharmaceutical CDMO Solution Market Forecast
10.3.4 Southeast Asia Pharmaceutical CDMO Solution Market Forecast
10.3.5 India Pharmaceutical CDMO Solution Market Forecast
10.3.6 Australia Pharmaceutical CDMO Solution Market Forecast
10.4 Europe Pharmaceutical CDMO Solution Forecast by Country (2024-2029)
10.4.1 Germany Pharmaceutical CDMO Solution Market Forecast
10.4.2 France Pharmaceutical CDMO Solution Market Forecast
10.4.3 UK Pharmaceutical CDMO Solution Market Forecast
10.4.4 Italy Pharmaceutical CDMO Solution Market Forecast
10.4.5 Russia Pharmaceutical CDMO Solution Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Solution Forecast by Region (2024-2029)
10.5.1 Egypt Pharmaceutical CDMO Solution Market Forecast
10.5.2 South Africa Pharmaceutical CDMO Solution Market Forecast
10.5.3 Israel Pharmaceutical CDMO Solution Market Forecast
10.5.4 Turkey Pharmaceutical CDMO Solution Market Forecast
10.5.5 GCC Countries Pharmaceutical CDMO Solution Market Forecast
10.6 Global Pharmaceutical CDMO Solution Forecast by Type (2024-2029)
10.7 Global Pharmaceutical CDMO Solution Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Pharmaceutical CDMO Solution Product Offered
11.1.3 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Recipharm AB Main Business Overview
11.1.5 Recipharm AB Latest Developments
11.2 Lonza Group
11.2.1 Lonza Group Company Information
11.2.2 Lonza Group Pharmaceutical CDMO Solution Product Offered
11.2.3 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Lonza Group Main Business Overview
11.2.5 Lonza Group Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Pharmaceutical CDMO Solution Product Offered
11.3.3 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Patheon (Thermo Fisher Scientific)
11.4.1 Patheon (Thermo Fisher Scientific) Company Information
11.4.2 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Offered
11.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Patheon (Thermo Fisher Scientific) Main Business Overview
11.4.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.5 Siegfried AG
11.5.1 Siegfried AG Company Information
11.5.2 Siegfried AG Pharmaceutical CDMO Solution Product Offered
11.5.3 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Siegfried AG Main Business Overview
11.5.5 Siegfried AG Latest Developments
11.6 SGS Quay Pharmaceuticals
11.6.1 SGS Quay Pharmaceuticals Company Information
11.6.2 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Offered
11.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SGS Quay Pharmaceuticals Main Business Overview
11.6.5 SGS Quay Pharmaceuticals Latest Developments
11.7 Curia
11.7.1 Curia Company Information
11.7.2 Curia Pharmaceutical CDMO Solution Product Offered
11.7.3 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Curia Main Business Overview
11.7.5 Curia Latest Developments
11.8 Societal CDMO
11.8.1 Societal CDMO Company Information
11.8.2 Societal CDMO Pharmaceutical CDMO Solution Product Offered
11.8.3 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Societal CDMO Main Business Overview
11.8.5 Societal CDMO Latest Developments
11.9 Aenova Group
11.9.1 Aenova Group Company Information
11.9.2 Aenova Group Pharmaceutical CDMO Solution Product Offered
11.9.3 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Aenova Group Main Business Overview
11.9.5 Aenova Group Latest Developments
11.10 Eurofins CDMO
11.10.1 Eurofins CDMO Company Information
11.10.2 Eurofins CDMO Pharmaceutical CDMO Solution Product Offered
11.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurofins CDMO Main Business Overview
11.10.5 Eurofins CDMO Latest Developments
11.11 Piramal Group
11.11.1 Piramal Group Company Information
11.11.2 Piramal Group Pharmaceutical CDMO Solution Product Offered
11.11.3 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Piramal Group Main Business Overview
11.11.5 Piramal Group Latest Developments
11.12 WuXi AppTec Group
11.12.1 WuXi AppTec Group Company Information
11.12.2 WuXi AppTec Group Pharmaceutical CDMO Solution Product Offered
11.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 WuXi AppTec Group Main Business Overview
11.12.5 WuXi AppTec Group Latest Developments
11.13 Fareva
11.13.1 Fareva Company Information
11.13.2 Fareva Pharmaceutical CDMO Solution Product Offered
11.13.3 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Fareva Main Business Overview
11.13.5 Fareva Latest Developments
11.14 Strides Pharma Science
11.14.1 Strides Pharma Science Company Information
11.14.2 Strides Pharma Science Pharmaceutical CDMO Solution Product Offered
11.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Strides Pharma Science Main Business Overview
11.14.5 Strides Pharma Science Latest Developments
11.15 Famar Health Care Service
11.15.1 Famar Health Care Service Company Information
11.15.2 Famar Health Care Service Pharmaceutical CDMO Solution Product Offered
11.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Famar Health Care Service Main Business Overview
11.15.5 Famar Health Care Service Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Solution Market Size 2018-2029
2.1.2 Pharmaceutical CDMO Solution Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical CDMO Solution Segment by Type
2.2.1 Active Pharmaceutical Ingredient (API) Manufacturing
2.2.2 Finished Dosage Formulation (FDF) Development and Manufacturing
2.2.3 Secondary Packaging
2.2.4 Others
2.3 Pharmaceutical CDMO Solution Market Size by Type
2.3.1 Pharmaceutical CDMO Solution Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical CDMO Solution Segment by Application
2.4.1 Innovative Medicine
2.4.2 Patented Drug
2.4.3 Patent Expired Drug
2.4.4 Others
2.5 Pharmaceutical CDMO Solution Market Size by Application
2.5.1 Pharmaceutical CDMO Solution Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
3 PHARMACEUTICAL CDMO SOLUTION MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Solution Market Size Market Share by Players
3.1.1 Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CDMO Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO SOLUTION BY REGIONS
4.1 Pharmaceutical CDMO Solution Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical CDMO Solution Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Solution Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO Solution by Country (2018-2023)
7.2 Europe Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO Solution by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO SOLUTION MARKET FORECAST
10.1 Global Pharmaceutical CDMO Solution Forecast by Regions (2024-2029)
10.1.1 Global Pharmaceutical CDMO Solution Forecast by Regions (2024-2029)
10.1.2 Americas Pharmaceutical CDMO Solution Forecast
10.1.3 APAC Pharmaceutical CDMO Solution Forecast
10.1.4 Europe Pharmaceutical CDMO Solution Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Solution Forecast
10.2 Americas Pharmaceutical CDMO Solution Forecast by Country (2024-2029)
10.2.1 United States Pharmaceutical CDMO Solution Market Forecast
10.2.2 Canada Pharmaceutical CDMO Solution Market Forecast
10.2.3 Mexico Pharmaceutical CDMO Solution Market Forecast
10.2.4 Brazil Pharmaceutical CDMO Solution Market Forecast
10.3 APAC Pharmaceutical CDMO Solution Forecast by Region (2024-2029)
10.3.1 China Pharmaceutical CDMO Solution Market Forecast
10.3.2 Japan Pharmaceutical CDMO Solution Market Forecast
10.3.3 Korea Pharmaceutical CDMO Solution Market Forecast
10.3.4 Southeast Asia Pharmaceutical CDMO Solution Market Forecast
10.3.5 India Pharmaceutical CDMO Solution Market Forecast
10.3.6 Australia Pharmaceutical CDMO Solution Market Forecast
10.4 Europe Pharmaceutical CDMO Solution Forecast by Country (2024-2029)
10.4.1 Germany Pharmaceutical CDMO Solution Market Forecast
10.4.2 France Pharmaceutical CDMO Solution Market Forecast
10.4.3 UK Pharmaceutical CDMO Solution Market Forecast
10.4.4 Italy Pharmaceutical CDMO Solution Market Forecast
10.4.5 Russia Pharmaceutical CDMO Solution Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Solution Forecast by Region (2024-2029)
10.5.1 Egypt Pharmaceutical CDMO Solution Market Forecast
10.5.2 South Africa Pharmaceutical CDMO Solution Market Forecast
10.5.3 Israel Pharmaceutical CDMO Solution Market Forecast
10.5.4 Turkey Pharmaceutical CDMO Solution Market Forecast
10.5.5 GCC Countries Pharmaceutical CDMO Solution Market Forecast
10.6 Global Pharmaceutical CDMO Solution Forecast by Type (2024-2029)
10.7 Global Pharmaceutical CDMO Solution Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Pharmaceutical CDMO Solution Product Offered
11.1.3 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Recipharm AB Main Business Overview
11.1.5 Recipharm AB Latest Developments
11.2 Lonza Group
11.2.1 Lonza Group Company Information
11.2.2 Lonza Group Pharmaceutical CDMO Solution Product Offered
11.2.3 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Lonza Group Main Business Overview
11.2.5 Lonza Group Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Pharmaceutical CDMO Solution Product Offered
11.3.3 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Patheon (Thermo Fisher Scientific)
11.4.1 Patheon (Thermo Fisher Scientific) Company Information
11.4.2 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Offered
11.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Patheon (Thermo Fisher Scientific) Main Business Overview
11.4.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.5 Siegfried AG
11.5.1 Siegfried AG Company Information
11.5.2 Siegfried AG Pharmaceutical CDMO Solution Product Offered
11.5.3 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Siegfried AG Main Business Overview
11.5.5 Siegfried AG Latest Developments
11.6 SGS Quay Pharmaceuticals
11.6.1 SGS Quay Pharmaceuticals Company Information
11.6.2 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Offered
11.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SGS Quay Pharmaceuticals Main Business Overview
11.6.5 SGS Quay Pharmaceuticals Latest Developments
11.7 Curia
11.7.1 Curia Company Information
11.7.2 Curia Pharmaceutical CDMO Solution Product Offered
11.7.3 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Curia Main Business Overview
11.7.5 Curia Latest Developments
11.8 Societal CDMO
11.8.1 Societal CDMO Company Information
11.8.2 Societal CDMO Pharmaceutical CDMO Solution Product Offered
11.8.3 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Societal CDMO Main Business Overview
11.8.5 Societal CDMO Latest Developments
11.9 Aenova Group
11.9.1 Aenova Group Company Information
11.9.2 Aenova Group Pharmaceutical CDMO Solution Product Offered
11.9.3 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Aenova Group Main Business Overview
11.9.5 Aenova Group Latest Developments
11.10 Eurofins CDMO
11.10.1 Eurofins CDMO Company Information
11.10.2 Eurofins CDMO Pharmaceutical CDMO Solution Product Offered
11.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurofins CDMO Main Business Overview
11.10.5 Eurofins CDMO Latest Developments
11.11 Piramal Group
11.11.1 Piramal Group Company Information
11.11.2 Piramal Group Pharmaceutical CDMO Solution Product Offered
11.11.3 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Piramal Group Main Business Overview
11.11.5 Piramal Group Latest Developments
11.12 WuXi AppTec Group
11.12.1 WuXi AppTec Group Company Information
11.12.2 WuXi AppTec Group Pharmaceutical CDMO Solution Product Offered
11.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 WuXi AppTec Group Main Business Overview
11.12.5 WuXi AppTec Group Latest Developments
11.13 Fareva
11.13.1 Fareva Company Information
11.13.2 Fareva Pharmaceutical CDMO Solution Product Offered
11.13.3 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Fareva Main Business Overview
11.13.5 Fareva Latest Developments
11.14 Strides Pharma Science
11.14.1 Strides Pharma Science Company Information
11.14.2 Strides Pharma Science Pharmaceutical CDMO Solution Product Offered
11.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Strides Pharma Science Main Business Overview
11.14.5 Strides Pharma Science Latest Developments
11.15 Famar Health Care Service
11.15.1 Famar Health Care Service Company Information
11.15.2 Famar Health Care Service Pharmaceutical CDMO Solution Product Offered
11.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Famar Health Care Service Main Business Overview
11.15.5 Famar Health Care Service Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical CDMO Solution Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Active Pharmaceutical Ingredient (API) Manufacturing
Table 3. Major Players of Finished Dosage Formulation (FDF) Development and Manufacturing
Table 4. Major Players of Secondary Packaging
Table 5. Major Players of Others
Table 6. Pharmaceutical CDMO Solution Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 9. Pharmaceutical CDMO Solution Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 12. Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Pharmaceutical CDMO Solution Revenue Market Share by Player (2018-2023)
Table 14. Pharmaceutical CDMO Solution Key Players Head office and Products Offered
Table 15. Pharmaceutical CDMO Solution Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical CDMO Solution Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Pharmaceutical CDMO Solution Market Size Market Share by Regions (2018-2023)
Table 20. Global Pharmaceutical CDMO Solution Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Pharmaceutical CDMO Solution Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Pharmaceutical CDMO Solution Market Size Market Share by Country (2018-2023)
Table 24. Americas Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 26. Americas Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 28. APAC Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Pharmaceutical CDMO Solution Market Size Market Share by Region (2018-2023)
Table 30. APAC Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 32. APAC Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 34. Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Pharmaceutical CDMO Solution Market Size Market Share by Country (2018-2023)
Table 36. Europe Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 38. Europe Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO Solution
Table 47. Key Market Challenges & Risks of Pharmaceutical CDMO Solution
Table 48. Key Industry Trends of Pharmaceutical CDMO Solution
Table 49. Global Pharmaceutical CDMO Solution Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Pharmaceutical CDMO Solution Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Pharmaceutical CDMO Solution Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Pharmaceutical CDMO Solution Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Recipharm AB Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 54. Recipharm AB Pharmaceutical CDMO Solution Product Offered
Table 55. Recipharm AB Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Recipharm AB Main Business
Table 57. Recipharm AB Latest Developments
Table 58. Lonza Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 59. Lonza Group Pharmaceutical CDMO Solution Product Offered
Table 60. Lonza Group Main Business
Table 61. Lonza Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Lonza Group Latest Developments
Table 63. Catalent Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 64. Catalent Pharmaceutical CDMO Solution Product Offered
Table 65. Catalent Main Business
Table 66. Catalent Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Catalent Latest Developments
Table 68. Patheon (Thermo Fisher Scientific) Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 69. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Offered
Table 70. Patheon (Thermo Fisher Scientific) Main Business
Table 71. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Patheon (Thermo Fisher Scientific) Latest Developments
Table 73. Siegfried AG Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 74. Siegfried AG Pharmaceutical CDMO Solution Product Offered
Table 75. Siegfried AG Main Business
Table 76. Siegfried AG Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Siegfried AG Latest Developments
Table 78. SGS Quay Pharmaceuticals Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 79. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Offered
Table 80. SGS Quay Pharmaceuticals Main Business
Table 81. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. SGS Quay Pharmaceuticals Latest Developments
Table 83. Curia Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 84. Curia Pharmaceutical CDMO Solution Product Offered
Table 85. Curia Main Business
Table 86. Curia Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Curia Latest Developments
Table 88. Societal CDMO Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 89. Societal CDMO Pharmaceutical CDMO Solution Product Offered
Table 90. Societal CDMO Main Business
Table 91. Societal CDMO Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Societal CDMO Latest Developments
Table 93. Aenova Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 94. Aenova Group Pharmaceutical CDMO Solution Product Offered
Table 95. Aenova Group Main Business
Table 96. Aenova Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Aenova Group Latest Developments
Table 98. Eurofins CDMO Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 99. Eurofins CDMO Pharmaceutical CDMO Solution Product Offered
Table 100. Eurofins CDMO Main Business
Table 101. Eurofins CDMO Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Eurofins CDMO Latest Developments
Table 103. Piramal Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 104. Piramal Group Pharmaceutical CDMO Solution Product Offered
Table 105. Piramal Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Piramal Group Main Business
Table 107. Piramal Group Latest Developments
Table 108. WuXi AppTec Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 109. WuXi AppTec Group Pharmaceutical CDMO Solution Product Offered
Table 110. WuXi AppTec Group Main Business
Table 111. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. WuXi AppTec Group Latest Developments
Table 113. Fareva Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 114. Fareva Pharmaceutical CDMO Solution Product Offered
Table 115. Fareva Main Business
Table 116. Fareva Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Fareva Latest Developments
Table 118. Strides Pharma Science Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 119. Strides Pharma Science Pharmaceutical CDMO Solution Product Offered
Table 120. Strides Pharma Science Main Business
Table 121. Strides Pharma Science Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Strides Pharma Science Latest Developments
Table 123. Famar Health Care Service Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 124. Famar Health Care Service Pharmaceutical CDMO Solution Product Offered
Table 125. Famar Health Care Service Main Business
Table 126. Famar Health Care Service Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Famar Health Care Service Latest Developments
Table 1. Pharmaceutical CDMO Solution Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Active Pharmaceutical Ingredient (API) Manufacturing
Table 3. Major Players of Finished Dosage Formulation (FDF) Development and Manufacturing
Table 4. Major Players of Secondary Packaging
Table 5. Major Players of Others
Table 6. Pharmaceutical CDMO Solution Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 9. Pharmaceutical CDMO Solution Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 12. Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Pharmaceutical CDMO Solution Revenue Market Share by Player (2018-2023)
Table 14. Pharmaceutical CDMO Solution Key Players Head office and Products Offered
Table 15. Pharmaceutical CDMO Solution Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical CDMO Solution Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Pharmaceutical CDMO Solution Market Size Market Share by Regions (2018-2023)
Table 20. Global Pharmaceutical CDMO Solution Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Pharmaceutical CDMO Solution Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Pharmaceutical CDMO Solution Market Size Market Share by Country (2018-2023)
Table 24. Americas Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 26. Americas Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 28. APAC Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Pharmaceutical CDMO Solution Market Size Market Share by Region (2018-2023)
Table 30. APAC Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 32. APAC Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 34. Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Pharmaceutical CDMO Solution Market Size Market Share by Country (2018-2023)
Table 36. Europe Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 38. Europe Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO Solution
Table 47. Key Market Challenges & Risks of Pharmaceutical CDMO Solution
Table 48. Key Industry Trends of Pharmaceutical CDMO Solution
Table 49. Global Pharmaceutical CDMO Solution Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Pharmaceutical CDMO Solution Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Pharmaceutical CDMO Solution Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Pharmaceutical CDMO Solution Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Recipharm AB Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 54. Recipharm AB Pharmaceutical CDMO Solution Product Offered
Table 55. Recipharm AB Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Recipharm AB Main Business
Table 57. Recipharm AB Latest Developments
Table 58. Lonza Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 59. Lonza Group Pharmaceutical CDMO Solution Product Offered
Table 60. Lonza Group Main Business
Table 61. Lonza Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Lonza Group Latest Developments
Table 63. Catalent Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 64. Catalent Pharmaceutical CDMO Solution Product Offered
Table 65. Catalent Main Business
Table 66. Catalent Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Catalent Latest Developments
Table 68. Patheon (Thermo Fisher Scientific) Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 69. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Offered
Table 70. Patheon (Thermo Fisher Scientific) Main Business
Table 71. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Patheon (Thermo Fisher Scientific) Latest Developments
Table 73. Siegfried AG Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 74. Siegfried AG Pharmaceutical CDMO Solution Product Offered
Table 75. Siegfried AG Main Business
Table 76. Siegfried AG Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Siegfried AG Latest Developments
Table 78. SGS Quay Pharmaceuticals Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 79. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Offered
Table 80. SGS Quay Pharmaceuticals Main Business
Table 81. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. SGS Quay Pharmaceuticals Latest Developments
Table 83. Curia Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 84. Curia Pharmaceutical CDMO Solution Product Offered
Table 85. Curia Main Business
Table 86. Curia Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Curia Latest Developments
Table 88. Societal CDMO Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 89. Societal CDMO Pharmaceutical CDMO Solution Product Offered
Table 90. Societal CDMO Main Business
Table 91. Societal CDMO Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Societal CDMO Latest Developments
Table 93. Aenova Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 94. Aenova Group Pharmaceutical CDMO Solution Product Offered
Table 95. Aenova Group Main Business
Table 96. Aenova Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Aenova Group Latest Developments
Table 98. Eurofins CDMO Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 99. Eurofins CDMO Pharmaceutical CDMO Solution Product Offered
Table 100. Eurofins CDMO Main Business
Table 101. Eurofins CDMO Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Eurofins CDMO Latest Developments
Table 103. Piramal Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 104. Piramal Group Pharmaceutical CDMO Solution Product Offered
Table 105. Piramal Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Piramal Group Main Business
Table 107. Piramal Group Latest Developments
Table 108. WuXi AppTec Group Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 109. WuXi AppTec Group Pharmaceutical CDMO Solution Product Offered
Table 110. WuXi AppTec Group Main Business
Table 111. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. WuXi AppTec Group Latest Developments
Table 113. Fareva Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 114. Fareva Pharmaceutical CDMO Solution Product Offered
Table 115. Fareva Main Business
Table 116. Fareva Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Fareva Latest Developments
Table 118. Strides Pharma Science Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 119. Strides Pharma Science Pharmaceutical CDMO Solution Product Offered
Table 120. Strides Pharma Science Main Business
Table 121. Strides Pharma Science Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Strides Pharma Science Latest Developments
Table 123. Famar Health Care Service Details, Company Type, Pharmaceutical CDMO Solution Area Served and Its Competitors
Table 124. Famar Health Care Service Pharmaceutical CDMO Solution Product Offered
Table 125. Famar Health Care Service Main Business
Table 126. Famar Health Care Service Pharmaceutical CDMO Solution Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Famar Health Care Service Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Solution Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pharmaceutical CDMO Solution Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pharmaceutical CDMO Solution Sales Market Share by Country/Region (2022)
Figure 8. Pharmaceutical CDMO Solution Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pharmaceutical CDMO Solution Market Size Market Share by Type in 2022
Figure 10. Pharmaceutical CDMO Solution in Innovative Medicine
Figure 11. Global Pharmaceutical CDMO Solution Market: Innovative Medicine (2018-2023) & ($ Millions)
Figure 12. Pharmaceutical CDMO Solution in Patented Drug
Figure 13. Global Pharmaceutical CDMO Solution Market: Patented Drug (2018-2023) & ($ Millions)
Figure 14. Pharmaceutical CDMO Solution in Patent Expired Drug
Figure 15. Global Pharmaceutical CDMO Solution Market: Patent Expired Drug (2018-2023) & ($ Millions)
Figure 16. Pharmaceutical CDMO Solution in Others
Figure 17. Global Pharmaceutical CDMO Solution Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Pharmaceutical CDMO Solution Market Size Market Share by Application in 2022
Figure 19. Global Pharmaceutical CDMO Solution Revenue Market Share by Player in 2022
Figure 20. Global Pharmaceutical CDMO Solution Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 22. APAC Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 23. Europe Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 25. Americas Pharmaceutical CDMO Solution Value Market Share by Country in 2022
Figure 26. United States Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Pharmaceutical CDMO Solution Market Size Market Share by Region in 2022
Figure 31. APAC Pharmaceutical CDMO Solution Market Size Market Share by Type in 2022
Figure 32. APAC Pharmaceutical CDMO Solution Market Size Market Share by Application in 2022
Figure 33. China Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Pharmaceutical CDMO Solution Market Size Market Share by Country in 2022
Figure 40. Europe Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Figure 41. Europe Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Figure 42. Germany Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 56. APAC Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 57. Europe Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 59. United States Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 60. Canada Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 63. China Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 64. Japan Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 65. Korea Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 67. India Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 68. Australia Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 69. Germany Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 70. France Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 71. UK Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 72. Italy Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 73. Russia Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 74. Spain Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 77. Israel Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 80. Global Pharmaceutical CDMO Solution Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Pharmaceutical CDMO Solution Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Pharmaceutical CDMO Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Solution Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pharmaceutical CDMO Solution Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pharmaceutical CDMO Solution Sales Market Share by Country/Region (2022)
Figure 8. Pharmaceutical CDMO Solution Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pharmaceutical CDMO Solution Market Size Market Share by Type in 2022
Figure 10. Pharmaceutical CDMO Solution in Innovative Medicine
Figure 11. Global Pharmaceutical CDMO Solution Market: Innovative Medicine (2018-2023) & ($ Millions)
Figure 12. Pharmaceutical CDMO Solution in Patented Drug
Figure 13. Global Pharmaceutical CDMO Solution Market: Patented Drug (2018-2023) & ($ Millions)
Figure 14. Pharmaceutical CDMO Solution in Patent Expired Drug
Figure 15. Global Pharmaceutical CDMO Solution Market: Patent Expired Drug (2018-2023) & ($ Millions)
Figure 16. Pharmaceutical CDMO Solution in Others
Figure 17. Global Pharmaceutical CDMO Solution Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Pharmaceutical CDMO Solution Market Size Market Share by Application in 2022
Figure 19. Global Pharmaceutical CDMO Solution Revenue Market Share by Player in 2022
Figure 20. Global Pharmaceutical CDMO Solution Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 22. APAC Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 23. Europe Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Pharmaceutical CDMO Solution Market Size 2018-2023 ($ Millions)
Figure 25. Americas Pharmaceutical CDMO Solution Value Market Share by Country in 2022
Figure 26. United States Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Pharmaceutical CDMO Solution Market Size Market Share by Region in 2022
Figure 31. APAC Pharmaceutical CDMO Solution Market Size Market Share by Type in 2022
Figure 32. APAC Pharmaceutical CDMO Solution Market Size Market Share by Application in 2022
Figure 33. China Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Pharmaceutical CDMO Solution Market Size Market Share by Country in 2022
Figure 40. Europe Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Figure 41. Europe Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Figure 42. Germany Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Pharmaceutical CDMO Solution Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Pharmaceutical CDMO Solution Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 56. APAC Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 57. Europe Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 59. United States Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 60. Canada Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 63. China Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 64. Japan Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 65. Korea Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 67. India Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 68. Australia Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 69. Germany Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 70. France Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 71. UK Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 72. Italy Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 73. Russia Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 74. Spain Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 77. Israel Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Pharmaceutical CDMO Solution Market Size 2024-2029 ($ Millions)
Figure 80. Global Pharmaceutical CDMO Solution Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Pharmaceutical CDMO Solution Market Size Market Share Forecast by Application (2024-2029)
